Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene designates a long non-coding RNA transcript located antisense to the C10orf11 gene. C10orf11 itself encodes a melanocyte-differentiation protein implicated in autosomal-recessive albinism, but the antisense transcript (ENSG00000236842) does not encode a protein, and its biological significance, disease association, or therapeutic relevance remain uncharacterized. It exists within the human genome as an annotated lncRNA locus, and currently lacks evidence for canonical molecular function, drug interaction, or biomarker utility[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to C10orf11 (ENSG00000236842).